BIOBOARD

Abstract

INDIA – Lack of access to technology ‘hampers detection of substandard drugs’. JAPAN – Daiichi Sankyo announces development of nucleic acid treatment for Duchenne muscular dystrophy utilizing proprietary technology. SINGAPORE – IBN creates unlimited source of human kidney cells. SINGAPORE – Dyesol and Singapore's NTU sign agreement. THE PHILIPPINES – Global biotech/GM crop plantings increase 100-fold from 1996. AUSTRALIA – Phosphagenics further expands pain portfolio. AUSTRALIA – Primary Health Care signs Australia distribution agreement for iGeneScreen™ prenatal test. AUSTRALIA – Folic acid in pregnancy linked with reduced autism risk. AUSTRALIA – Phylogica and Bio-Link collaborate to commercialize anti-inflammatory Phylomers. AUSTRALIA – ABRAXANE® plus gemcitabine improves survival in Phase III study of patients with advanced pancreatic cancer. CANADA – Verisante Technology, Inc. announces first sales of aura, a revolutionary medical device for the detection of skin cancer. EUROPE – Project eyes robust medical technology for poor countries. UNITED KINGDOM – Asthma sufferers have more lung fungi. UNITED KINGDOM – Pioneering drug discovery gets major funding to move to next stage. UNITED STATES – Gilead's sofosbuvir for hepatitis C meets primary endpoint in fourth pivotal Phase III study. UNITED STATES – Eleven Biotherapeutics publishes data on EBI-005, a novel IL-1 inhibitor protein for topical treatment of dry eye disease. UNITED STATES – Phase I/II trial of ADXS-HPV in anal cancer conducted by Brown University Oncology Group. UNITED STATES – Scopolamine: An old drug with new psychiatric applications. UNITED STATES – New bioengineered ears look and act like the real thing. UNITED STATES – To trap a rainbow, slow down light. UNITED STATES – AB SCIEX responds to milk contamination concerns with new method to detect dicyandiamide.